Literature DB >> 21171015

Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.

Aung Ko Win1, Sean P Cleary, James G Dowty, John A Baron, Joanne P Young, Daniel D Buchanan, Melissa C Southey, Terrilea Burnett, Patrick S Parfrey, Roger C Green, Loïc Le Marchand, Polly A Newcomb, Robert W Haile, Noralane M Lindor, John L Hopper, Steven Gallinger, Mark A Jenkins.   

Abstract

Cancer risks for a person who has inherited a MUTYH mutation from only one parent (monoallelic mutation carrier) are uncertain. Using the Colon Cancer Family Registry and Newfoundland Familial Colon Cancer Registry, we identified 2,179 first- and second-degree relatives of 144 incident colorectal cancer (CRC) cases who were monoallelic or biallelic mutation carriers ascertained by sampling population complete cancer registries in the United States, Canada and Australia. Using Cox regression weighted to adjust for sampling on family history, we estimated that the country-, age- and sex-specific standardized incidence ratios (SIRs) for monoallelic mutation carriers, compared to the general population, were: 2.04 (95% confidence interval, CI 1.56-2.70; p < 0.001) for CRC, 3.24 (95%CI 2.18-4.98; p < 0.001) for gastric cancer, 3.09 (95%CI 1.07-12.25; p = 0.07) for liver cancer and 2.33 (95%CI 1.18-5.08; p = 0.02) for endometrial cancer. Age-specific cumulative risks to age 70 years, estimated using the SIRs and US population incidences, were: for CRC, 6% (95%CI 5-8%) for men and 4% (95%CI 3-6%) for women; for gastric cancer, 2% (95%CI 1-3%) for men and 0.7% (95%CI 0.5-1%) for women; for liver cancer, 1% (95%CI 0.3-3%) for men and 0.3% (95%CI 0.1-1%) for women and for endometrial cancer, 4% (95%CI 2-8%). There was no evidence of increased risks for cancers of the brain, pancreas, kidney, lung, breast or prostate. Monoallelic MUTYH mutation carriers with a family history of CRC, such as those identified from screening multiple-case CRC families, are at increased risk of colorectal, gastric, endometrial and possibly liver cancers.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171015      PMCID: PMC3291738          DOI: 10.1002/ijc.25870

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

Review 1.  Base-excision repair of oxidative DNA damage.

Authors:  Sheila S David; Valerie L O'Shea; Sucharita Kundu
Journal:  Nature       Date:  2007-06-21       Impact factor: 49.962

2.  Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

Authors:  L Thorstensen; H Qvist; S Heim; G J Liefers; J M Nesland; K E Giercksky; R A Lothe
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

3.  Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China.

Authors:  Yuanying Zhang; Xiaorong Liu; Yimei Fan; Jianhua Ding; Ailing Xu; Xuefu Zhou; Xu Hu; Ming Zhu; Xiaomei Zhang; Suping Li; Jianzhong Wu; Haixia Cao; Jintian Li; Yaping Wang
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

4.  Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.

Authors:  Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger
Journal:  J Natl Cancer Inst       Date:  2004-11-03       Impact factor: 13.506

5.  A kindred with MYH-associated polyposis and pilomatricomas.

Authors:  Silvana Baglioni; German Melean; Francesca Gensini; Marco Santucci; Marco Scatizzi; Laura Papi; Maurizio Genuardi
Journal:  Am J Med Genet A       Date:  2005-04-15       Impact factor: 2.802

6.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

7.  Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.

Authors:  Kylie L Gorringe; Manasa Ramakrishna; Louise H Williams; Anita Sridhar; Samantha E Boyle; Jennifer L Bearfoot; Jason Li; Michael S Anglesio; Ian G Campbell
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

8.  Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.

Authors:  Natalie Jones; Stefanie Vogt; Maartje Nielsen; Daria Christian; Petra A Wark; Diana Eccles; Emma Edwards; D Gareth Evans; Eamonn R Maher; Hans F Vasen; Frederik J Hes; Stefan Aretz; Julian R Sampson
Journal:  Gastroenterology       Date:  2009-04-23       Impact factor: 22.682

9.  Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.

Authors:  Stefanie Vogt; Natalie Jones; Daria Christian; Christoph Engel; Maartje Nielsen; Astrid Kaufmann; Verena Steinke; Hans F Vasen; Peter Propping; Julian R Sampson; Frederik J Hes; Stefan Aretz
Journal:  Gastroenterology       Date:  2009-09-02       Impact factor: 22.682

10.  Genetic variants in MUTYH are not associated with endometrial cancer risk.

Authors:  Katie A Ashton; Anthony Proietto; Geoffrey Otton; Ian Symonds; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2009-01-26       Impact factor: 2.857

View more
  43 in total

1.  Common MUTYH mutations and colorectal cancer risk in multiethnic populations.

Authors:  Flavio Lejbkowicz; Ilana Cohen; Ofra Barnett-Griness; Mila Pinchev; Jen Poynter; Stephen B Gruber; Gad Rennert
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?

Authors:  Rajani Bharati; Mark A Jenkins; Noralane M Lindor; Loïc Le Marchand; Steven Gallinger; Robert W Haile; Polly A Newcomb; John L Hopper; Aung Ko Win
Journal:  Gynecol Oncol       Date:  2014-03-11       Impact factor: 5.482

3.  Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

Authors:  Evan J Walker; Julia Carnevale; Christina Pedley; Amie Blanco; Salina Chan; Eric A Collisson; Margaret A Tempero; Andrew H Ko
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

4.  Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews.

Authors:  Guy Rosner; Dani Bercovich; Yael Etzion Daniel; Hana Strul; Naomi Fliss-Isakov; Meirav Ben-Yehoiada; Erwin Santo; Zamir Halpern; Revital Kariv
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

5.  Type and frequency of MUTYH variants in Italian patients with suspected MAP: a retrospective multicenter study.

Authors:  Maria Teresa Ricci; Sara Miccoli; Daniela Turchetti; Davide Bondavalli; Alessandra Viel; Michele Quaia; Elisa Giacomini; Viviana Gismondi; Lupe Sanchez-Mete; Vittoria Stigliano; Aline Martayan; Filomena Mazzei; Margherita Bignami; Luigina Bonelli; Liliana Varesco
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

6.  High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.

Authors:  Rania Abdelmaksoud-Dammak; Imen Miladi-Abdennadher; Ali Amouri; Nabil Tahri; Lobna Ayadi; Abdelmajid Khabir; Foued Frikha; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

7.  Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer.

Authors:  Aung Ko Win; James G Dowty; Sean P Cleary; Hyeja Kim; Daniel D Buchanan; Joanne P Young; Mark Clendenning; Christophe Rosty; Robert J MacInnis; Graham G Giles; Alex Boussioutas; Finlay A Macrae; Susan Parry; Jack Goldblatt; John A Baron; Terrilea Burnett; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; John L Hopper; Michelle Cotterchio; Steven Gallinger; Noralane M Lindor; Katherine M Tucker; Ingrid M Winship; Mark A Jenkins
Journal:  Gastroenterology       Date:  2014-01-17       Impact factor: 22.682

8.  Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort.

Authors:  Kelly Fulk; Holly LaDuca; Mary Helen Black; Dajun Qian; Yuan Tian; Amal Yussuf; Carin Espenschied; Kory Jasperson
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 9.  When you're strange: Unusual features of the MUTYH glycosylase and implications in cancer.

Authors:  Alan G Raetz; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2019-06-08

10.  The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer.

Authors:  M Casper; M Acalovschi; F Lammert; V Zimmer
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.